QUANTITATIVE STUDIES OF PHYTOHEMAGGLUTININ-INDUCED DNA AND RNA SYNTHESIS IN NORMAL AND AGAMMAGLOBULINEMIC LEUKOCYTES by Tormey, Douglass C. et al.
QUANTITATIVE STUDIES OF PHYTOHEMAGGLUTININ-INDUCED 
DNA  AND  RNA  SYNTHESIS  IN  NORMAL  AND 
AGAMMAGLOBULINEMIC  LEUKOCYTES* 
Bx DOUGLASS C. TORMEY,~; M.D., ROBERTA KAMIN, a.~ 
H. HUGH FUDENBERG,  M.D. 
(From the Section of Hematology and Immunology, DeparOnont of Medicine, University 
of California School of Medicine, San Francisco) 
(Received for publication 13 January 1967) 
Recent investigation of the lymphocytes of normal human subjects in vitro 
have shown that such cells undergo transformation and cytokinesis with con- 
comitant synthesis of protein, ribonucleic acid  (RNA),  and deoxyribonucleic 
acid (DNA) when stimulated by antigens to which the subject has been pre- 
vionsly sensitized  (1-5).  Staphylococcal products  (3),  specific antiserum  to 
human leukocytes (5, 6), and streptolysin S (7) produce similar effects. Certain 
plant substances also have mitogenic properties, particularly phytohemagglu- 
tinin (PHA), an extract of the kidney bean Pkaseolus vulgaris (8-14). 
The mitogenic effect of PHA on lymphocytes can be determined quantita- 
tively by measuring the amount of labeled precursor incorporated into RNA 
(13) and DNA (14). Since the basic defect in agammaglobullnemia appears  to 
be located in the lymphocytes, their progenitors, or their progeny (15, 16), these 
assays were employed to investigate the lymphocytes of patients with acquired 
agammaglobullnemia. In the present study the PHA-induced response of leuko- 
cytes  from patients  with  primary  and  secondary agammaglobulinemia  was 
compared with the response of leukocytes from normal donors. The effect of 
sera from the agammaglobulinemic patients on PHA-initiated synthesis of RNA 
and DNA by normal leukocytes was also investigated. 
Materials and Metkods 
PaEcnts.--The study group consisted of nine adult patients with "acquired" agamma- 
globullnemia, all of whom were receiving monthly gamma globulin injections. [Infants with 
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congenital agammaglobulinemia were not studied bemuse the amount of blood required for 
assay  (60 ml) seemed to contraindicate studies on infants.] 
Seven of the patients (No. 1-7) have "primary" agammaglobulinemia with serum immune 
globulin levels 2-10% of normal. All have had recurrent infections during a period of at least 
5 yr; none of the seven has shown clinical or laboratory evidence of malignancy. Patients 8 and 
9  have "secondary" agammaglobulinemia associated with lymphosarcoma and a  thymoma, 
respectively. In patient 8 lymphosarcoma was diagnosed by laparotomy in 1951.  Biopsy of 
jejunal and mesenteric lymph nodes in  1957  and of a  subcutaneous deltoid nodule in  1963 
showed changes typical of malignant lymphoma (reticulum cell type). From 1957 to 1963 the 
patient was treated elsewhere at various times with nitrogen mustard, irradiation, and chlor- 
ambucil. A  serum protein electrophoretic pattern, first obtained in November 1962, showed 
severe hypogammaglobulinemia. Monthly gamma globulin injections were begun in July 1963. 
Since that time the patient has received no antitumor therapy and has remained asympto- 
matic. In patient 9, a diagnosis of thymoma and hypogammaglobulinemia was established in 
June 1964.  Subsequently the thymoma has gradually increased in size.  During the course of 
this study the patient was receiving 15 mg of prednisone daily.  Whether the immunologic 
deficiency antedated the development of the associated disorders in these two patients is not 
known. 
Serum  amt Cell Preparations.--Blood  samples were obtained from each subject by veni- 
puncture. A  20-ml aliquot was placed in a  sterile tube and allowed to clot at 37°C without 
anticoagulant. The serum was removed aseptically. 
Leukocyte suspensions were prepared from the remaining blood as described previously 
(14). Aliquots, 10 ml each, were added to each of four sterile 13-ml screw-cap centrifuge tubes 
containing 0.2  ml of heparin  (heparin sodium,  Upjohn Co.,  Kalamazoo,  Mich.,  1000  USP 
units/ml) and mixed by gentle inversion. Usually the cells were allowed to settle for 2 hr at 
room temperature; however, blood obtained from several patients with a  very slow erythro- 
cyte sedimentation rate, as is characteristic of agammaglobulinemia, was gently centrifuged. 
The leukocyte-containing supernatant plasma was removed. An aliquot was diluted with 3% 
acetic acid and the cell concentration determined with a hemocytometer. The desired volume 
of the plasma-cell suspension was centrifuged for 6 min. The cell pellet was resuspended in 
5 ml of 0.05% sterile trypsin (Nutritional  Biochemical  Corp.,  Cleveland,  Ohio) and  incu- 
bated at 37°C for 7 rain, during which the cells were gently dispersed several times with a 
pipette. The cell suspension was then centrifuged and the cell pellet resuspended in culture 
medium for planting. The final cell concentration was 1.0 X  106 per ml. 
Culture Medium.--Eagle's HeLa medium (EHM)  (Colorado Serum Co.,  Denver, Colo.), 
modified by the addition of glycine (10  -~ ~), serine (10  -2 M) and inositol (2 X  10  -3 M), was 
sterilized by passage through a  Millipore filter, 0.22 #  pore size.  Selas filtered sterile bovine 
serum (Colorado Serum Co.) or serum collected aseptically from normal or agammaglobuline- 
mic subjects was added to the sterile EHM in a  ratio of  1 part serum to 9 parts EHM. A 
single lot of bovine serum was used for all assays. 
Mitogen.--Phytohemagglutil~ln-M  (PHA-M)  (Difco  Laboratories,  Detroit,  Mich.,  lot 
No. 485336,  100 mg per vial)  was used  as  the  lymphocyte  mitogen.  The  content  of  each 
vial was  dissolved in 5  ml of sterile triple-distilled water;  1 ml of this stock  solution was 
arbitrarily designated as possessing 1 unit of mitogenic activity. A fresh stock solution was 
prepared for each experiment; before use it was diluted tenfold with triple-distilled water so 
that 0.1 ml contained 0.01 unit of PHA. 
Assay Procedures.--The  assay systems for DNA (14) and RNA (13) are shown graphically 
in Fig. 1. Each assay was performed in duplicate. In earJa experiment cells from a normal donor 
were incubated in bovine serum, autologous serum, and serum from an agammagiobulinemic 
patient; cells from the agammagiobulinemic patient were incubated in bovine serum, autol- 
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the same ABO and Rh blood group as the agammaglobulinemic patient, although varying these 
factors has had no apparent effect on leukocyte incorporation of labeled precursor (14, 17-19, 
footnotes  1 and  2).  The normal  donors were selected from a  pool of volunteers in whom 
preliminary studies had shown a normal rate of incorporation of thymidine-2-14C  into leuko- 
cyte DNA by the assay method used in this study. A control series of duplicate cultures in 
which 0.1  ml of distilled water was substituted  for PHA-M were assayed simultaneously in 
each experiment. No incorporation was obtained in the absence of PHA-M. 
DNA  Assay.--Duplieate  cultures  of  leukocytes were  prepared  by  suspending  approxi- 
mately 3.0 X  10  6 cells in 3 ml of medium in 16 X  150 mm rubber-stoppered test tubes con- 
taming either 0.1  ml of the diluted  PHA-M solution  (i.e.,  0.01  unit/culture)  or 0.1  ml of 
triple-distilled water. All cultures were gassed with 5% CO2 in air and incubated on a 4 ° slant 
at 37°C.  After 48 hr (Fig. 1), 0.1 ml of EHM supplemented with 3  ×  10  -5 -  amethopterin 
(methotrexate sodium, Lederle Laboratories, Pearl River, N. Y.) plus 1.5 X  10  -s g  adenosine 
DNA  ASSAY  SEQUENCE 
0  48  64  70 
I  {48hr)  I  (16hr)  I  (6hr)  I 
PLANT  AMETH-A  TDR  2-14C  HARVEST 
RNA  ASSAY  SEQUENCE 
0  42  66  68 
I  (42h,~  ,I  (24h,~  I (2ho I 
PLANT  PHA-M  CDR-3H  HARVEST 
FiG. 1.  Schematic representation of assay systems for incorporation of labeled precursors 
into  leukocyte  DNA  and  RNA  in  phytohemagglutinin-stimulated  leukocytes  in  in  vitro 
culture.  Tdr-2-t4C,  thymidine-2-14C;  Cdr-H  s,  tritiated  cytidine;  Ameth-A,  amethopterin 
plus adenosine; PHA-M, phytohemagglutinin. 
(Grade A, Calbiochem, Los Angeles, Calif.) (Ameth-A) was added to each culture,  s After further 
incubation for  16 hr, 0.1  ml of EHM containing 30 gg/ml of thymidine-2-14C  (Tdr-2-t4C) 
(specific activity, 3.66 mc/mmole, New England Nuclear Corp., Boston, Mass.) was added to 
each culture. Incubation was then continued for an additional 6 hr. After each addition, the 
cultures were regassed with 5% CO2 in air before being returned to the incubator. Trypan blue 
staining showed  that,  on an  average, 80-95%  of the cells  (both agammaglobulinemic and 
normal) were viable at the end of the culture procedure. 
At the end of the 70 hr assay period, the cells were harvested and the acid-insoluble residue 
was obtained by successive treatment of the cells with 10% trichloroacetic acid, 80% ethanol, 
and a  1:1 mixture of absolute ethanol and ethyl ether. The acid-insoluble residue was dried, 
then dissolved in 0.5 ml of 90% formic acid. A 0.2 ml aliquot of each sample was added to 20 
ml of ANPO  (c~-napthylphenyloxazole,  Packard Instrument  Co., Downers  Grove, Ill.) for 
z Tormey, D. C., and G. C. Mueller. Unpublished data. 
Tormey, D. C., and H. H. Fudenberg. Unpublished observations. 
s The addition of Ameth-A blocks endogenous synthesis of thymidine and the concomitant 
synthesis  of DNA.  This effect is  subsequently  reversed in  a  synchronous  manner  by the 
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counting in a Packard Tri-Carb liquid scintillation spectrometer (21). The radioactivity in the 
residue obtained by this method is DNAse sensitive (14). 
RNA  Assay.--Cultures  were prepared  in  duplicate,  as  they were for  the  DNA assay, 
except that PHA was added not at the time of planting but after a 42 hr incubation period 
(Fig. 1). The cultures were incubated for 24 hr in the presence of PHA, then 0.1 ml of EHM 
containing 1.39 #g/ml of HS-cytidine (specific activity 2.34 c/mmole, New England Nuclear 
l°°1- 
60 
4O 
2O 
o  N'I 
100r 
6O 
,t0 
2O 
o 
I 
6O 
.t0 
0 
Normal  1 
AUTOLOGOUS SERUM 
NORMAL  SERUM 
.N.p;  .N:D;  I~ 
BOVINE SERUM 
2  3  4  5 
CELL SOURCE 
[] :DNA 
[]  =RNA 
,N.p:  N.,h  N:D: 
6  7  8  9 
FtG. 2.  Incorporation of labeled precursor (thymidine-2-14C or tritiated cytidine) into DNA 
and  RNA of leukocytes from nine agammaglobulinemic patients.  In each experiment ceils 
from one patient and from a normal donor of the same blood type were cultured simultaneously 
in Eagle's HeLa medium supplemented by each of three serum sources (bovine, patient's, or 
normal). Incorporation of labeled precursor by the normal cells in each experiment was arbi- 
trarily designated as 100. The numerals indicate the quantity of labeled precursor incorporated 
into the DNA or RNA of the cells of each  agammaglobulinemic patient as compared  with 
incorporation by the respective control cells. N.D., no  done. 
Corp.) was added to each. After each addition the cultures were gassed with 5% CO~ in air. 
After further incubation for 2 hr,  the cells were harvested. The acid-insoluble residue was 
prepared  and the radioactivity counted as described for DNA. With the method used,  the 
radioactivity in the acid-insoluble residue is releasable by RNAse (13).  At the end  of the 
culture period, 8095% of both agammaglobulinemic and normal cells were viable as shown 
by trypan blue staining. 
Tritiated cytidine rather than tritiated uridine was used for the RNA assay because the 
pool size of cytidine in mammalian cells is generally much smaller than that of uridine. McIntyre 
and Ebangh (11) showed that RNA synthesis begins within the first 24 Jar of exposure to PHA. 
The exact time curve of this period of RNA synthesis has been clarified  by Mueller and Le D.  C.  TORMEY, R.  KAMIN,  AND  H.  H.  FUDENBEEG  867 
Mahieu (13), who have shown that RNA production increases exponentially as soon as PHA 
is added to the cells.  DNA synthesis begins 30-36 hr after the addition of PHA, and this lag 
is independent of the time the cells have already been maintained in vitro. Thus, the incorpora- 
tion of labeled cytidine into DNA under the conditions of these experiments is insignificant 
(13). 
RESULTS 
In  the present study we measured the PHA-induced response of agamma- 
globulinemic cells cultured in vitro in medium containing  bovine, normal,  or 
autologous serum. In evaluating the results, incorporation of radioactivity into 
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l~ko. 3.  Effect of agammaglobulinemic serum on incorporation  of labeled precursor into 
DNA and RNA of normal leukocytes. Normal cells were incubated in Eagle's HeLa medium 
(EHM) supplemented with bovine serum or by serum of each of nine agammaglobulinemic 
patients. The bars indicate the degree of incorporation of labeled precursor in cells cultured in 
EHM-agammaglobulinemic serum as compared with incorporation of the same cells in EHM- 
bovine serum (arbitrarily designated  as 100). The degree of incorporation by cells in EHM 
supplemented with  sera  from  normal  human  donors  ranges  from  80 to 140 in this assay 
system. 
the DNA and RNA of the cells of each patient was compared directly with the 
incorporation of radioactivity by cells from the respective control donor simi- 
larly cultured in all three media. To facilitate comparison,  incorporation by the 
control cells in each experiment was arbitrarily designated as 100 (about 2500 
cpm per culture). 
Incorporation of label by the cells of the agammaglobulinemic  patients was 
considerably lower than that of normal leukocytes, regardless  of which of the 
three types of serum was used to supplement the medium (Fig. 2). 
In a separate series of experiments, the effect of sera from the agammaglobu- 868  DNA  AND RNA  SYNTHESIS IN LEUKOCYTES 
linemic  patients  on incorporation  of Tdr-2-1*C and  H3-cytidine  into  normal 
leukocytes was compared with incorporation of label by normal cells suspended 
in bovine serum. As shown in Fig. 3, sera from four patients (No. 1, 2, 5, and 6) 
enhanced incorporation  of Tdr-2-14C into leukocyte DNA, whereas sera from 
another four patients  (No. 3, 4,  7, and 8) had no significant  effect.  Only one 
serum (patient  9) had an inhibitory effect on incorporation  of label.  Normal 
human sera neither significantly  enhanced nor inhibited incorporation of Tdr- 
2-14C into DNA; the range of incorporation was 0.8 to 1.4 times that found with 
bovine serum.  The various agammaglobulinemic  sera had essentially the same 
effect on incorporation of labeled precursor into leukocyte RNA, except in the 
case of the patient  with treated  lymphosarcoma (No.  8).  The  serum of this 
patient enhanced incorporation of radioactivity into RNA but not into DNA. 
In  none  of the  experiments  was  there  significant  incorporation  of labeled 
precursor into either DNA or RNA in the absence of PHA. 
DISCUSSION 
Because of its mitogenic properties, PHA is being widely used to investigate 
the function of the lymphocyte in health and disease (4-14, 22-27, footnotes 1 
and 4). Recent studies with in vitro culture systems have shown that PHA is 
capable of stimulating  rabbit lymph nodes to produce specific antibody (27) 
and human lymphocytes to synthesize gamma globulin (1) and specific anti- 
body (2, 4,  10), although  the latter is controversial.  Circumstantial  evidence 
suggests that some of the progeny arising after lymphocyte transformation and 
mitosis become plasma cells (28). Since the number of plasma cells (and hence 
their production of gamma globulin)  is markedly decreased in agammaglobu- 
linemia,  data obtained in studies of the lymphocytes of such patients might 
provide an explanation  for the failure  of plasma cell genesis in this group of 
disorders  and perhaps aid in elucidating the fundamental defect. 
Theoretically, a serum factor capable of preventing transformation of lym- 
phocytes into plasma cells might be responsible  for the paucity of plasma cells 
in patients  with  agammaglobulinemia.  This hypothesis seems unlikely since 
the sera of our patients with primary agammaglobulinemia had no inhibitory 
effect on  the  PHA-induced synthesis of DNA and  RNA by normal  human 
lymphocytes. The alternate  explanation  that the defect in primary agamma- 
globulinemia is located in the cells is supported by the decreased synthesis of 
DNA and RNA by agammaglobulinemic  cells in the standard  assay systems 
used in the present experiments. These observations are in accord with current 
data suggesting that primary acquired agammaglobulinemia is genetically deter- 
mined and that the lymphocytes of such patients are defective (5, 15, 16, 22-25, 
29-36).  Presumably,  the  genetically  determined  defect  of  the  lymphocytes 
4 Fudenberg, H. H., S. Salmon, and R. M. Kamin. In preparation. D. C. TOP,-M~EY, R. ~IN,  AND  H. H. ~FUDENBERG  869 
that  precludes  antigen-induced  transformation  of  the  ceils  into  plasma  cell 
precursors also precludes a  normal  biochemical  response to PHA. The inter- 
pretations of the present findings are supported by a previous study from this 
laboratory, which demonstrated that lymphocytes from patients with primary 
agammaglobulinemia showed decreased incorporation of tritiated uridine into 
RNA after 48 hr of exposure to PHA, rabbit antiserum to human lymphocytes, 
or antigen  (5).  They are also in  accord  with  the observation that  although 
lymphocytes from patients with agammaglobulinemia appear capable of under- 
going morphologic  transformation when stimulated by PHA (24-26,  33), they 
synthesize less gamma globulin  than  do normal lymphocytes (4,  10,  23, 33). 
This synthetic defect is  not unexpected in view of the decreased synthesis of 
gamma globulin in vivo in these patients (37-39). Whether the in vitro defect in 
DNA and RNA synthesis shown in the present experiments is  also associated 
with  an  in  vivo defect is  conjectural.  Such  an  association,  however, might 
result in failure of cellular replication in response to antigen. 
In contrast to the sera of the patients with primary agammaglobulinemia,  the 
serum of the patient  with secondary agammaglobulinemia  and  a  slowly en- 
larging  thymoma (No. 9) inhibited synthesis of both DNA and RNA in normal 
leukocytes. Sera from patients  with active lymphopoietic tumors have  been 
shown  to  inhibit  PHA-induced  synthesis  of DNA  in  normal  lymphocytes.  1 
Hence, the inhibitory effect of our patient's serum may only reflect tumor ac- 
tivity and have no relationship  to the agammaglobulinemia.  Alternatively, it 
may be attributable to corticosteroid therapy, which the patient was receiving 
at the time of the study; small  doses of prednisone inhibit synthesis of DNA 
and RNA by PHA-stimulated leukocytes in culture (40) and therefore may do 
so in vivo. 
In a previous study in this laboratory (5),  synthesis of RNA by cells from 
patients  with  secondary agammaglobulinemia  was  not  decreased  during  48 
and 72 hr of continuous culture. The apparent lack of accord with the results 
of the present study probably is related to differences in the method of assay. 
In the present experiments,  incorporation of H3-cytidine  was determined for 
a  2 hr period during the time of maximal  RNA synthesis (Fig.  1) instead of 
during the total period of culture after the addition of PHA. Synthesis of RNA 
increases  exponentially during the first 24 hr after the addition of PHA (13). 
Incorporation of HS-cytidine is therefore greater during the last 2 hr of the 24 
hr period than during the total period of synthesis after the addition of PHA. 
The assay system used in the present experiments thus provides a more sensi- 
tive index of maximal RNA synthesis than the systems used previously in our 
laboratory and others. These results suggest the possibility that RNA synthesis 
in response to an antigen or a nonspecific stimulant such as PHA may be better 
sustained in secondary than in primary agammaglobulinemia. 
In any event, the present data suggest that one or more defects are present 870  DNA  AND  RNA  SYNTHESIS  IN  LEUKOCYTES 
within the lymphocytes of patients with acquired agammaglobulinemia. Both 
antigenic stimulation and PHA produce characteristic biochemical responses in 
normal cells in vitro. The lesser response of agammaglobulinemic cells in vitro 
suggests that a  defective response to antigenic stimulation may also exist in 
vivo and may be the result of or associated with impaired cellular replication. 
Alternatively, the  lymphocytes in agammaglobulinemia may be  normal but 
unresponsive to such stimulation. According to a recent theory (15), the normal 
population of lymphocytes consists of two types of cells, morphologically un- 
distinguishable but differing in ability to produce antibody. The normal lym- 
phocytes of one type may be capable of responding to PHA or antigen, whereas 
the other type may be incapable of such response. The lymphocytes of agamma- 
globulinemic patients thus might consist entirely of a  population of such un- 
responsive cells. This hypothesis seems unlikely since preliminary studies with 
this test system have demonstrated a  partial metabolic defect in the cells of 
parents of patients with "acquired" agammaglobulinemia even though their 
serum gamma globulin levels were normal. This partial defect in the parents' 
cells  indicates that acquired agammaglobulinemia is in reality a  genetically 
determined disorder (41). 
SIYMMARY 
Leukocytes from  nine  patients  with  acquired  agammaglobulinemia  were 
studied in vitro.  Synthesis of deoxyribonucleic acid  (DNA)  and ribonculeic 
acid (RNA) induced by phytohemagglutinin was measured by determination 
of the degree of incorporation of labeled precursor. Synthesis of both DNA and 
RNA was decreased in the agammaglobulinemic cells. The presence of an in- 
inhibitor in the patients' sera could not be demonstrated. These results suggest 
that the basic defect in agammaglobulinemia is cellular rather than humoral. 
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